Skip to main content
. 2019 Oct 15;7(1):26–37. doi: 10.1016/j.gendis.2019.10.002

Table 2.

Advantages and limitations of different genomic, transcriptomic and proteomics based platforms in Common variable immunodeficiency disease. ELISA, Enzyme-linked immunosorbent assay; SNP, Single nucleotide polymorphism.

Technology Basic technique Advantages Limitations Ref
Genome-wide Association Studies
  • Identify common genetic variants (>5% allele frequency)

  • Variations in SNPs analyzed throughout genome

  • Frequent genetic variations considered pointers of disease causing loci

  • Hypothesis free approach

  • Low cost

  • High resolution

  • Many loci for single trait concurrently analyzed

  • Large number of genes can be studied concurrently

  • Validation of results required in large data sets and different population

  • Detects association and not causation

  • Not predictive and explain less heritability

32,64, 65, 66, 67
Sanger Sequencing
  • Fluorescent dye-labeled bases

  • DNA fragments read through capillary electrophoresis

  • Long reads (~750bp)

  • High Sensitivity

  • High accuracy

  • Gold Standard

  • Can be applied to large number of patients

  • Low throughput

  • Time consuming

  • Detects genetic variation in known region

  • Cannot detect translocations

  • Cannot detect copy number changes

37,44,49,68, 69, 70
Pyro-sequencing
  • Sequencing by synthesis

  • Chemiluminescent based detection

  • More sensitive than Sanger sequencing

  • % mutated vs. wild-type DNA

  • Short Read length

  • Limited to known hot-spots

  • Limited accuracy to detect homopolymer changes

  • Limited scalability

27,35,55,60
Next Generation Sequencing
  • Involves array based massive parallel sequencing

  • Genomic DNA is fragmented and ligated for library preparation followed by amplification and sequencing

  • High throughput

  • Low background noise signal

  • High sensitivity

  • ➢ Large dynamic range

  • Nano-grams of starting material required

  • Short reads (~100-500bp)

  • Amplification bias

  • Massive set-up and infrastructure required

  • Limited bioinformatics

Targeted Sequencing
  • Detects genetic variations in pre-designed gene of interest

  • Data is easy to handle

  • Not useful where hot-spots or gene of interest is not known

31,38,39,42,43
Whole Exome Sequencing
  • Detects genetic variations in protein-coding genome (1% of total genome)

  • Detects nucleotide variations, small insertions and deletions

  • Does not detect genetic variations in non-protein coding genome

  • Gene expression regulatory regions are not detected

25,37,41,44,45,47,48
Whole Genome Sequencing
  • Detects all genetic variations (protein coding and regulatory regions)

  • Detects all nucleotide variations and genome reorganizations (insertion, deletion, inversion, duplication or translocations)

  • Large size of human genome sequencing expensive

  • Large complex data is generated

30,48
Microarray
  • Hybridization of complementary sequences via hydrogen bonds to immobilized DNA molecule

  • Samples are fluorescent dyes

  • Low cost

  • High throughput

  • Well-defined hybridization and analysis pipelines

  • Easy sample preparation

  • Large number of samples per run

  • Analysis based on pre-defined sequence

  • Limited dynamic range

  • Non-specific hybridization and High background

  • Low sensitivity

  • High variance for low expressed genes

  • Does not identify splice variants, paralogs and novel transcripts

50,51
RNA-Sequencing
  • Quantifies and sequence RNA using Next generation technology

  • Analyze transcriptome of gene expression pattern encoded in RNA

  • High throughput

  • High dynamic range

  • High sensitivity

  • Low background noise signal

  • No hybridization

  • Detects alternative spliced sites, paralogous genes, SNP and non-coding RNAs identification

  • Protocols not fully optimized

  • High power computing facilities required

  • High set-up and run costs

  • Complex computational analysis

  • Complex analysis of splice variants

7,52,56
Epigenome profiling
  • Quantifies DNA methylation at multiple CpG sites

  • Sodium bisulfite treatment – Gold Standard

  • Detects gene expression in regions with high and low CpG density

  • Low cost

  • Not every methylated region can be captured with affinity enrichment technique

  • Sensitive to CpG density and copy numbers

  • Does not identify 5 mC sites

  • No absolute quantification of methylation levels

55,56,60
Fourier-transform infrared (FTIR) spectroscopy
  • Monitor biochemical changes on the basis of spectral features which reflect chemical and molecular composition

  • Rapid

  • Inexpensive

  • Non-invasive technique

  • High noise

  • Complex data

  • High end computational methods (chemometrics) required for data analysis

71